DIAGNOS Successfully Passed ISO Annual Surveillance Audit

Diagnos Inc.

BROSSARD, QUEBEC--(Marketwired - Dec. 19, 2017) - DIAGNOS Inc. ("DIAGNOS", "the Corporation" or "we") (TSX VENTURE:ADK)(OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today that it has successfully passed the ISO 13485 - Medical devices and ISO 9001 annual surveillance audit for its CARA healthcare platform.